| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 04/20/2004 | US6723335 Methods and compositions for treating intervertebral disc degeneration |
| 04/15/2004 | WO2004031188A1 Bicyclic heteroaromatic compounds as kinase inhibitors |
| 04/15/2004 | WO2004031177A1 2-aminobenzimidazole derivative |
| 04/15/2004 | WO2004031159A1 Substituted 4-(indazol-3-yl)phenols as estrogen receptor (er) ligands and their use in the treatment of inflammatory diseases |
| 04/15/2004 | WO2004031158A1 Indazolecarboxamide derivatives, preparation and use thereof as cdk1, cdk2 and cdk4 inhibitors |
| 04/15/2004 | WO2004031125A1 Spiro compounds, medicinal compositions containing the same and intermediates of the compounds |
| 04/15/2004 | WO2004030691A1 Sustained release preparation containing nk4 |
| 04/15/2004 | WO2004030689A1 Composition containing eosinophil cationic protein |
| 04/15/2004 | WO2004030683A1 Remedies |
| 04/15/2004 | WO2004030671A2 Use of 4-amino-quinazolines as anti cancer agents |
| 04/15/2004 | WO2004030669A1 Use of tricyclic amides for the treatment of disorders of calcium homeostasis |
| 04/15/2004 | WO2004030658A1 Enteric composition for the manufacture of soft capsule wall |
| 04/15/2004 | WO2004014859A3 Process for preparing quinolin antibiotic intermediates |
| 04/15/2004 | WO2004005309A3 Novel nonsteroidal anti-inflammatory substances, compositions and methods for their use |
| 04/15/2004 | WO2003106381A3 Human adam-10 inhibitors |
| 04/15/2004 | WO2003099845A3 Fas peptide mimetics and uses thereof |
| 04/15/2004 | WO2003053359A3 1,3-bis-(substituted-phenyl)-2-propyn-1-ones and their use to treat disorders |
| 04/15/2004 | WO2003050250B1 Chondrocyte precursors derived from human embryonic stem cells |
| 04/15/2004 | WO2003049723A8 Use of protease-activated receptor-2 inhibitor in the manifacture of a medicament for treating delayed hypersensitivity |
| 04/15/2004 | WO2003008038A9 Electro-medical device for use with biologics |
| 04/15/2004 | WO2002069980A3 Pharmaceutically effective ginsenosides and their use |
| 04/15/2004 | WO2002061052A8 An improved in vitro method of culturing mammalian cells for autologous cell implantation/transplantation methods |
| 04/15/2004 | WO2002016553B1 Regulator gene and system useful for the diagnosis and therapy of osteoporosis |
| 04/15/2004 | WO2002000611A9 Fmoc-l-leucine and derivatives thereof as ppar-gamma agonists |
| 04/15/2004 | WO2002000227A8 Use of lanthanum compounds for the treatment of bone diseases |
| 04/15/2004 | US20040073958 Transgenic animal having drug metabolism enzyme gene and utilization thereof |
| 04/15/2004 | US20040073026 Cyclic protein tyrosine kinase inhibitors |
| 04/15/2004 | US20040073024 Phosphorus-containing compounds and uses thereof |
| 04/15/2004 | US20040072997 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 04/15/2004 | US20040072904 Powder mixture of aminobutyric acid and solid polyol; therapy for brain disorders; central nervous system disorders; analgesics; headaches |
| 04/15/2004 | US20040072888 Administering pyrazoloanthrone compound |
| 04/15/2004 | US20040072883 Cyclooxygenase-2 selective inhibitors, compositions and methods of use |
| 04/15/2004 | US20040072881 Dietetics; osteoporosis; muscular disorders |
| 04/15/2004 | US20040072878 2,3-Diphenylpropionic acid derivatives or their salts, medicines or cell adhesion inhibitors containing the same, and their usage |
| 04/15/2004 | US20040072867 Antiemetics, antidepressants, anxiolytic agents, antitussive agents |
| 04/15/2004 | US20040072850 Caspase inhibitors and uses thereof |
| 04/15/2004 | US20040072833 Antidepressants; anxiolytic agents; eating disorders; antiulcer agents; drug abuse; Alzheimer's disease |
| 04/15/2004 | US20040072832 Anticancer agents; antiinflammatory agents |
| 04/15/2004 | US20040072820 Naphthyl compounds, intermediates, compositions, and methods of use |
| 04/15/2004 | US20040072818 Antiinflammatory agents; autoimmune disease; anticancer agents |
| 04/15/2004 | US20040072804 Anticancer agents; skin disorders; bone disorders |
| 04/15/2004 | US20040072803 Novel compounds for modulating cell proliferation |
| 04/15/2004 | US20040072772 Survival Regulating Kinase, SRK, involved in cell signal transduction; method of detecting a protein kinase activity in a human SRK polypeptide |
| 04/15/2004 | US20040072762 Diazocine derivatives and their use as tryptase inhibitors |
| 04/15/2004 | US20040072726 Decoy is an NF- kappa B decoy, an ets decoy, or a chimera decoy of NF- kappa B and ets. The disease is cerebral aneurysm, cancer, aortic detachment, post-angioplasty restenosis, chronic articular rheumatism, asthma, atopic etc. |
| 04/15/2004 | US20040072725 Orinithine and/or one or more branched amino acids(leucine, isoleucine and valine) in a concentration effective for treating or preventing inflammatory disease such as arthritis |
| 04/15/2004 | US20040072286 Comprises nucleotide sequences coding synovium/cartilage inflammation-linked messenger 1 (SCIM-1) for diagnosis and treatment of rhematoid arthritis |
| 04/15/2004 | US20040072238 Integrin binding polipeptide for diagnosis, prevention and treatment of renal failure, thrombosis, osteoporosis, cancers and diabetes |
| 04/15/2004 | US20040072188 Comprises nucleotide sequences coding B-cell activating factor receptor (BAFF-R) for diagnosis, prevention, treatment and/or delay of cancers, lymphomas and autoimmune diseases |
| 04/15/2004 | US20040071735 Bone and muscular disorder treatment |
| 04/15/2004 | US20040071712 Modified peptides as therapeutic agents |
| 04/15/2004 | US20040071655 Binding agent |
| 04/15/2004 | US20040069523 Use of Vitamin D-Derivatives in the Treatment of Osteoporosis and related bone disorders, as well as novel vitamin D3-Deviratives |
| 04/15/2004 | CA2500904A1 Composition containing eosinophil cationic protein |
| 04/15/2004 | CA2500869A1 Spiro compounds, medicinal compositions containing the same and intermediates of the compounds |
| 04/15/2004 | CA2500844A1 Bicyclic heteroaromatic compounds as kinase inhibitors |
| 04/15/2004 | CA2500663A1 Enteric composition for the manufacture of soft capsule wall |
| 04/15/2004 | CA2500527A1 Remedies |
| 04/15/2004 | CA2499736A1 Substituted 4-(indazol-3-yl)phenols as estrogen receptor (er) ligands and their use in the treatment of inflammatory diseases |
| 04/14/2004 | EP1408117A1 Glycoprotein and process for producing the same |
| 04/14/2004 | EP1407783A1 Remedies for hernia |
| 04/14/2004 | EP1407777A1 Preventives or remedies for arthritis |
| 04/14/2004 | EP1407770A1 Tgf-beta superfamily production/secretion promoter |
| 04/14/2004 | EP1407768A2 The potassium channel opener retigabine for the treatment of diseases |
| 04/14/2004 | EP1407677A2 Compositions comprising partly-hydrolized fish gelatin and use thereof |
| 04/14/2004 | EP1407041A1 Method for obtaining a titrated preparation of algae and resulting titrated preparations |
| 04/14/2004 | EP1407004A2 Ex-vivo priming for generating cytotoxic t lymphocytes specific for non-tumor antigens to treat autoimmune and allergic disease |
| 04/14/2004 | EP1406926A2 Novel neurotrophic factors |
| 04/14/2004 | EP1406916A2 Genes associated with mechanical stress, expression products therefrom, and uses thereof |
| 04/14/2004 | EP1406910A1 Novel bisphosphonate derivatives, their preparation methods and uses |
| 04/14/2004 | EP1406908A1 Morpholine-bridged pyrazolopyridine derivatives |
| 04/14/2004 | EP1406899A2 Phenylacetamido-thiazole derivatives, process for their preparation and their use as antitumor agents |
| 04/14/2004 | EP1406898A1 Substituted piperazine compounds and their use as fatty acid oxidation inhibitors |
| 04/14/2004 | EP1406894A1 Piperazine oxime derivatives having nk-1 receptor antagonistic activity |
| 04/14/2004 | EP1406891A1 Thiochromenones used to combat painful conditions and neurodegenerative diseases |
| 04/14/2004 | EP1406878A1 4-(benzylidene-amino)-3-(methylsulfanyl)-4h-(1, 2, 4) triazin-5-one derivatives having a pde-iv inhibiting and tnf-antagonistic effect for the treatment of cardiac diseases and allergies |
| 04/14/2004 | EP1406875A1 N-heterocyclic inhibitors of tnf-alpha expression |
| 04/14/2004 | EP1406873A2 Fluoropyrrolidines as dipeptidyl peptidase inhibitors |
| 04/14/2004 | EP1406872A2 Dipeptidyl peptidase inhibitors for the treatment of diabetes |
| 04/14/2004 | EP1406867A2 Thiolalkyl benzoic acid derivatives |
| 04/14/2004 | EP1406866A1 Inhibitors of the ice/ced-3 family of cysteine proteases |
| 04/14/2004 | EP1406694A1 Electro-medical device for use with biologics |
| 04/14/2004 | EP1406678A1 Drug delivery matrices to enhance wound healing |
| 04/14/2004 | EP1406666A2 Adenoviral vectors with cell type specificity for mesenchymal cells |
| 04/14/2004 | EP1406664A2 Targeting chemical compounds to cells |
| 04/14/2004 | EP1406660A1 Combination of an aldosterone receptor antagonist and an hmg coa reductase inhibitor |
| 04/14/2004 | EP1406656A2 METHODS OF ADMINISTERING ANTI-TNF$g(a) ANTIBODIES |
| 04/14/2004 | EP1406644A2 Modified proteins, designer toxins, and methods of making thereof |
| 04/14/2004 | EP1406641A2 Krill and/or marine extracts for prevention and/or treatment of cardiovascular diseases, arthritis, skin cancer, diabetes, premenstrual syndrome and transdermal transport |
| 04/14/2004 | EP1406634A1 Combination of drospirenone and an estrogen sulphamate for hrt |
| 04/14/2004 | EP1406626A2 Sulphonyl aryl hydroxamates and their use as mmp inhibitors |
| 04/14/2004 | EP1406622A2 Dipeptidyl peptidase inhibitors for the treatment of diabetes |
| 04/14/2004 | EP1406611A2 Method for treating fibrotic diseases or other indications |
| 04/14/2004 | EP1406609A2 Substituted aryl compounds as novel cyclooxygenase-2 selective inhibitors, compositions and methods of use |
| 04/14/2004 | EP1406608A2 Nitrosated and nitrosylated nebivolol and its metabolites, compositions and methods of use |
| 04/14/2004 | EP1406602A2 Use of sulfonyl aryl or heteroaryl hydroxamic acids and derivatives thereof as aggrecanase inhibitors |
| 04/14/2004 | EP1406591A1 Pharmaceutical composition for nasal delivery of estradiol and norethisterone |
| 04/14/2004 | EP1406571A2 Liposomal encapsulation of glycosaminoglycans for the treatment of arthritic joints |
| 04/14/2004 | EP1406516A1 Potassium calcium citrate compositions and methods for their production |
| 04/14/2004 | EP1375465A9 Cyclooctanone derivative and cyclodecanone derivative, and use thereof |